1. Home
  2. IMXI vs ALLO Comparison

IMXI vs ALLO Comparison

Compare IMXI & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$15.94

Market Cap

469.3M

Sector

Technology

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.32

Market Cap

539.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
ALLO
Founded
1994
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.3M
539.4M
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
IMXI
ALLO
Price
$15.94
$2.32
Analyst Decision
Buy
Strong Buy
Analyst Count
2
15
Target Price
$15.00
$8.35
AVG Volume (30 Days)
297.3K
14.4M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.09
EPS
1.08
N/A
Revenue
$319,601,000.00
N/A
Revenue This Year
$0.83
N/A
Revenue Next Year
$1.49
$142,416.42
P/E Ratio
$14.69
N/A
Revenue Growth
16.68
N/A
52 Week Low
$8.58
$0.86
52 Week High
$15.94
$4.46

Technical Indicators

Market Signals
Indicator
IMXI
ALLO
Relative Strength Index (RSI) 68.17 47.02
Support Level $15.78 $1.92
Resistance Level N/A $2.71
Average True Range (ATR) 0.04 0.35
MACD 0.00 -0.04
Stochastic Oscillator 93.75 17.43

Price Performance

Historical Comparison
IMXI
ALLO

About IMXI International Money Express Inc.

International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: